Kao Corp. Stock
€32.70
Your prediction
Kao Corp. Stock
Pros and Cons of Kao Corp. in the next few years
Pros
Cons
Performance of Kao Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Kao Corp. | 6.030% | 0.215% | 0.215% | -19.695% | -4.581% | -2.388% | -34.990% |
| Unicharm Corp. | 5.080% | 0.000% | -0.980% | - | 3.909% | - | - |
| Pola Orbis Holdings Inc. | 1.520% | 0.000% | -2.899% | -15.723% | -3.597% | -48.855% | -69.266% |
| Kose Corp | 3.620% | -0.694% | -10.063% | -19.209% | 2.143% | -69.574% | -78.333% |
News
Claude responded: Alignment Healthcare's CEO Sold Shares — But the Real Risk Is Policy, Not InsidersAlignment Healthcare's CEO Sold Shares — But the Real Risk Is Policy, Not Insiders
On May 11, 2026, John E. Kao, Chief Executive Officer of Alignment Healthcare (NASDAQ:ALHC), reported the indirect sale of 298,000 shares of common stock for a total transaction value of
Alignment Healthcare Backs Q2 Outlook as Stable Costs, New Markets Lift Margin Hopes
Alignment Healthcare (NASDAQ:ALHC) executives said the company remains confident in its second-quarter outlook, citing stable medical cost
Alignment Healthcare CEO Sells $2.1 Million in Shares. Here's What Investors Should Know
John E. Kao, Chief Executive Officer of Alignment Healthcare (NASDAQ:ALHC), reported the indirect sale of 118,000 shares for a transaction value of about $2.06 million, according to a SEC Form 4


